Bristol-Myers Squibb Company and the Bristol-Myers Squibb Foundation announced at the XVIII International AIDS Conference in Vienna the community-based projects that it is currently supporting in resource-poor regions across Africa to help combat the challenge of HIV and tuberculosis co-infection...Recently, Bristol-Myers Squibb Foundation has provided backing for new innovative community-based projects focusing on working closely with local communities to improve the diagnosis, support, education and treatment for HIV-positive members who are also infected with tuberculosis...Four projects have received...technical assistance grants to aid communities in sub-Saharan Africa, KwaZulu-Natal, Eastern Cape Provinces and Luthando.